Compare KZR & MGLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | KZR | MGLD |
|---|---|---|
| Founded | 2015 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 44.5M | 44.8M |
| IPO Year | 2018 | 2021 |
| Metric | KZR | MGLD |
|---|---|---|
| Price | $6.75 | $1.04 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 44.5K | ★ 239.1K |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $34,876,734.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.53 | $0.64 |
| 52 Week High | $6.86 | $1.38 |
| Indicator | KZR | MGLD |
|---|---|---|
| Relative Strength Index (RSI) | 69.05 | 48.21 |
| Support Level | $6.06 | $0.98 |
| Resistance Level | N/A | $1.04 |
| Average True Range (ATR) | 0.18 | 0.13 |
| MACD | 0.04 | -0.01 |
| Stochastic Oscillator | 85.62 | 20.41 |
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
The Marygold Companies Inc is a holding company that intends to focus on financial services. It is currently directing its investments towards financial services and the emerging Fintech space.